CIB Stock Analysis: Grupo Cibest S.A. | NYSE
Banks - Regional | NYSE, USA | Market Cap: 20.471m USD | 12M Return: 41.6% | US40090E1064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 25.7M
EPS Trend: 88.9%
Qual. Beats: 0
Rev. Trend: -13.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Grupo Cibest S.A. (formerly Bancolombia S.A., renamed in May 2025) is one of Colombias largest diversified banking groups, founded in 1875 and headquartered in Medellín. The company operates as a full-service financial institution offering deposit products, credit solutions including mortgages and credit cards, capital markets services, investment banking, insurance, and trust and fiduciary services across Colombia and international markets.
As a diversified bank in the Financials sector, Grupo Cibest serves retail and corporate clients through an extensive multi-channel distribution network that includes physical branches, mobile branches, ATMs, digital banking, and banking correspondents. The group also operates Nequi, a digital banking platform, alongside specialized services such as cash management, trade finance, and asset management.
- Net interest margin expands as Colombia holds benchmark rate elevated
- Loan growth accelerates on strong consumer and corporate credit demand
- Nequi digital platform scales amid rising fintech competition
| Net Income: 7601b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.81 > 1.0 |
| NWC/Revenue: -576.0% < 20% (prev -533.3%; Δ -42.73% < -1%) |
| CFO/TA 0.04 > 3% & CFO 13448b > Net Income 7601b |
| Net Debt (2287b) to EBITDA (11384b): 0.20 < 3 |
| Current Ratio: 0.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (236.2m) vs 12m ago -1.78% < -2% |
| Gross Margin: 61.00% > 18% (prev 58.59%; Δ 2.41% > 0.5%) |
| Asset Turnover: 12.19% > 50% (prev 11.34%; Δ 0.85% > 0%) |
| Interest Coverage Ratio: 0.81 > 6 (EBIT TTM 10359b / Interest Expense TTM 12851b) |
| A: -0.71 (Total Current Assets 24191b - Total Current Liabilities 285398b) / Total Assets 369162b |
| B: 0.03 (Retained Earnings 12438b / Total Assets 369162b) |
| C: 0.03 (EBIT TTM 10359b / Avg Total Assets 371897b) |
| D: 0.12 (Book Value of Equity 38783b / Total Liabilities 329108b) |
| Altman-Z'' = -4.22 = D |
As of November 21, 2026, the stock is trading at USD 81.55 with a total of 302,555 shares traded. Over the past week, the price has changed by -8.89%, over one month by -14.94%, over three months by -14.63% and over the past year by +41.60%.
Current recommended Stop Loss: 75.70 (which is 7.2% or 1.9 ATR below the current price).
Grupo Cibest S.A. has received a consensus analysts rating of 3.27. Therefore, it is recommended to hold CIB.
- StrongBuy: 2
- Buy: 1
- Hold: 7
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 90.5 | 11% |
Market Cap COP = 68516b (20.5b USD * 3346.9899902344 USD.COP)
P/E Trailing = 5.798
P/E Forward = 7.215
P/S = 2.2706
P/B = 1.7795
P/EG = 0.4343
Revenue TTM = 45345b COP
EBIT TTM = 10359b COP
EBITDA TTM = 11384b COP
Long Term Debt = 15666b COP (from longTermDebt, last quarter)
Short Term Debt = 7187b COP (from shortTermDebt, last quarter)
Debt = 25541b COP (from shortLongTermDebtTotal, last quarter) + Leases 1344b
Net Debt = 2287b COP (calculated: Debt 25541b - CCE 23255b)
Enterprise Value = 70802b COP (68516b + Debt 25541b - CCE 23255b)
Interest Coverage Ratio = 0.81 (Ebit TTM 10359b / Interest Expense TTM 12851b)
EV/FCF = 6.39x (Enterprise Value 70802b / FCF TTM 11088b)
FCF Yield = 15.66% (FCF TTM 11088b / Enterprise Value 70802b)
FCF Margin = 24.45% (FCF TTM 11088b / Revenue TTM 45345b)
Net Margin = 16.76% (Net Income TTM 7601b / Revenue TTM 45345b)
Gross Margin = 61.00% ((Revenue TTM 45345b - Cost of Revenue TTM 17683b) / Revenue TTM)
Gross Margin QoQ = 60.84% (prev 64.60%)
Tobins Q-Ratio = 0.19 (Enterprise Value 70802b / Total Assets 369162b)
Interest Expense / Debt = 50.31% (Interest Expense 12851b / Debt 25541b)
Taxrate = 30.67% (3177b / 10359b)
NOPAT = 7182b (EBIT 10359b * (1 - 30.67%))
Current Ratio = 0.08 (Total Current Assets 24191b / Total Current Liabilities 285398b)
Debt / Equity = 0.66 (Debt 25541b / totalStockholderEquity, last quarter 38783b)
Debt / EBITDA = 0.20 (Net Debt 2287b / EBITDA 11384b)
Debt / FCF = 0.21 (Net Debt 2287b / FCF TTM 11088b)
Total Stockholder Equity = 37937b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.04% (Net Income 7601b / Total Assets 369162b)
RoE = 20.04% (Net Income TTM 7601b / Total Stockholder Equity 37937b)
RoCE = 19.33% (EBIT 10359b / Capital Employed (Equity 37937b + L.T.Debt 15666b))
RoIC = 8.10% (NOPAT 7182b / Invested Capital 88684b)
WACC = 5.11% (E(68516b)/V(94057b) * Re(7.02%) + (debt cost/tax rate unavailable))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -84.91 | Cagr: -0.80%
[DCF] Terminal Value 73.10% ; FCFF base≈12369b ; Y1≈10847b ; Y5≈8764b
[DCF] Fair Price = 1.27m (EV 140666b - Net Debt 2287b = Equity 138379b / Shares 109.0m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
[DCF] Fair Price = 1.27m (out of range, set to none)
EPS Correlation: 88.89 | EPS CAGR: 15.31% | SUE: -0.48 | # QB: 0
Revenue Correlation: -13.46 | Revenue CAGR: -0.33% | SUE: 0.71 | # QB: 0
EPS current Quarter (2027-03-31): EPS=3.05 | Chg30d=-4.78% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=10.31 | Chg30d=-3.43% | Revisions=-25% | GrowthEPS=+28.0% | GrowthRev=+4.7%
EPS next Year (2027-12-31): EPS=11.61 | Chg30d=+0.25% | Revisions=-25% | GrowthEPS=+12.6% | GrowthRev=+10.2%
[Analyst] Revisions Ratio: -50% (up=0, down=3)